LPCN compared with ZNTL: revenue, margins and what each company keeps, and the suppliers and customers both name

LPCNLipocine Inc.

Mkt capRevenueRevenue

ZNTLZentalis Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LPCNLipocine Inc.

ZNTLZentalis Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LPCNLipocine Inc.

1.42▼−1.39%· delayed

Mkt cap$11.9MRevenue$190,099Q2 FY26Revenue$2MFY25

ZNTLZentalis Pharmaceuticals, Inc.

1.85▼−5.58%· post 1.85· delayed

After hoursNov 2 '26delayed

Mkt cap$140.5MRevenue$27MQ4 FY24Revenue—

Compare

After hoursNov 2 '26delayed

LPCNLipocine Inc.

ZNTLZentalis Pharmaceuticals, Inc.

1.42▼−1.39%delayed

Price

1.85▼−5.58%post 1.85delayed

$11.9M

Mkt cap

$140.5M

Q2 FY26$190,099

Revenue

$27MQ4 FY24

FY25$2M

Revenue

—

LPCN1.42▼−1.39%vsZNTL1.85▼−5.58%After hoursNov 2 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

LPCN: latest quarter is a loss; flow not drawable. ZNTL: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LPCN 0

None

Shared 0

No disclosed counterparties: LPCN.

Only ZNTL 5

PFEPfizersupplier

IMNMImmunomecustomer

GSKGSKsupplier

—Dana‑Farber Cancer Instituteunlistedsupplier

1 more · ZNTL chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

LPCN, solidZNTL, dashed